Category Intelligence
July 29, 2026

AI funding share rose from 1.6% to 7.4% vs Healthcare's stable 12-18% range

4.6×
AI funding share growth (2019-2026)
12.3-18.4%
Healthcare funding share range (2019-2026)
2.1×
AI vs Healthcare median round size in 2026
  • AI funding share climbed from 1.6% in 2019 to 7.4% in 2026
  • Healthcare & Life Sciences funding share held between 12.3% and 18.4%
  • AI median round size peaked at €27.5M in 2026, surpassing Healthcare's €13.1M

Across the 9,536 deals Brouky tracks from 2019 to 2026, Artificial Intelligence & Data has notably increased its share of total funding rounds, rising from 1.6% in 2019 to 7.4% so far in 2026. This more than quadrupling contrasts with Healthcare & Life Sciences, which maintained a relatively stable share fluctuating between 12.3% and 18.4% during the same period. The dataset's coverage expanded over time, which should be considered when interpreting these trends.

Healthcare & Life Sciences commanded a peak share of 18.4% in 2020 but declined to around 12.5% so far in 2026. Meanwhile, AI's median deal size showed significant volatility, peaking at €27.5M in 2026, nearly double Healthcare's median round size of €13.1M that year. Earlier years saw Healthcare median rounds consistently larger, but AI's median deal size surged past Healthcare's in the final year observed.

MEDIAN ROUND SIZE BY CATEGORY AND YEAR

Stage-level data reveals that AI seed rounds have a median size of approximately €4.6M, slightly larger than Healthcare's €3.7M seeds. At Series A, both sectors show comparable median rounds around €15M. However, at later stages, AI's Series B and Series C+ medians (€39.0M and €91.7M respectively) are larger than Healthcare's (€38.3M and €67.0M), though AI's smaller deal volume at these stages tempers direct comparisons.

Share this article

Related insights

Explore the full dataset

Brouky tracks 36,000+ investors and 100,000+ investments across 84,000+startups. Search by country, stage, and sector.